Enter your terms above and click the 'Search' button.

Showing articles 0 to 10 of 10 Filter Applied: monoclonal antibodies (Click to remove) Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies Neurol 92:663-674, Johansen, A.,et al, 2019 GQ1b-Seronegative Miller Fisher Syndrome Associated with Pembrolizumab J Neuro-Ophthal 39:394-396, Green, K.E.,et al, 2019 Acute demyelinating polyneuropathy induced by nivolumab JNNP 89:435-437, Fukumoto, Y.,et al, 2018 Pembrolizumab-Induced Myasthenia Gravis Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018 Myasthenia Gravis NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016 Acute Demyelinating Polyneuropathy Caused by Nivolumab in a Man with Metastatic Non-Small Cell Lung Cancer J Gerontol Geriatr Res 5:3, Sabeeh-Ur-Rehman, B. & Bhaumik, S., 2016 Neurological Immune-Related Adverse Events of Ipilimumab Pract Neurol 13:278-280, Bot, I.,et al, 2013 Monoclonal Antibody Therapies and Neurologic Disorders Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008 Treatment of Guillain-Barre Syndrome with Anti-T Cell Monoclonal Antibodies JNNP 54:51-54, Feasby,T.E., 1991 OKT3 Encephalopathy Ann Neurol 28:837-838, Coleman,A.E.&Norman,D.J., 1990 Showing articles 0 to 10 of 10